KKM Approves Sinovac Vaccine For Kids Aged 5 To 11
The decision was made following a meeting with the Drug Control Authority (DCA).
Subscribe to our Telegram channel for the latest stories and updates.
The Health Ministry (KKM) has approved the Sinovac vaccine to be given to children aged 5 to 11.
According to Free Malaysia Today, Health Director-General Dr Noor Hisham Abdullah said the decision was made after a meeting with the Drug Control Authority (DCA) today, 3 March.
A conditional approval was also given for the Sinovac vaccine to be administered to those aged 12 and above.
The national immunisation programme for children (PICKids) has successfully administered the first dose of Pfizer Covid-19 vaccines to 904,368 (25.5%) children in the age bracket since 3 February.
PICKids aims to vaccinate 3.6 million children aged five to 11 ahead of the new school year to minimise the risk of infections and clusters forming among children and school staff.
KKM has granted conditional approval for the use of Paxlovid pills to treat Covid-19 patients who are at risk of suffering severe symptoms too.
Dr Noor Hisham said Paxlovid pills are not meant to replace Covid-19 vaccines.
The health ministry wishes to announce that the conditional approval registration still requires quality, safety and efficacy information on the vaccine product, which will be continuously monitored and evaluated by the National Pharmaceutical Regulatory Agency based on the latest data from time to time. This is to ensure that the comparison of benefit over risk for the vaccine remains positive.
Health Director-General Dr Noor Hisham Abdullah
Share your thoughts with us via TRP’s Facebook, Twitter, and Instagram.
